Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BI 765049 + Ezabenlimab for Advanced Solid Cancers
Recruiting1 awardPhase 1
Orange, California
This trial is for adults with advanced solid tumors whose previous cancer treatment was not successful. People with the B7-H6 marker or colorectal cancer are eligible. The study is testing two medicines, BI 765049 and BI 754091, which may help the immune system fight cancer. The purpose is to find the highest tolerable dose of BI 765049 given alone and in combination with BI 754091. Participants can stay in the study for up to three years and will receive BI 765049 and BI 754091 through IV infusions every three weeks. Doctors will monitor participants' health and tumor size throughout the trial
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.